Breaking News
Monday , October 23 2017
Home / Tag Archives: Aurobindo Pharma

Tag Archives: Aurobindo Pharma

Aurobindo Pharma to expand product portfolio in the US

Aurobindo Pharma is expanding its product portfolio in the US with high-value drugs. The portfolio mix is complemented with the introduction of high-value products and the future pipeline will include oncology, hormones, depot injections, inhalers, biosimilars, patches and films. The addressable market for the company’s total 429 Abbreviated New Drug ... Read More »

Aurobindo Pharma receives USFDA approval for Atomoxetine Capsules

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture Atomoxetine capsules, 10 mg, 18 mg, 25 mg, 40 mg, 60 mg, 80 mg and 100 mg. Atomoxetine capsules are the AB rated generic equivalent of Eli Lilly and Company’s Strattera capsules. The product ... Read More »